Loading
Head-to-head · Cannabinoids
Two cannabinoids, two different profiles. Educational overview — not medical advice.
The short answer
THC (tetrahydrocannabinol) is the cannabinoid associated with the classic cannabis high. It binds CB1 receptors in the brain and produces euphoria, appetite effects, and altered perception. CBD (cannabidiol) is non-intoxicating and interacts with the endocannabinoid system indirectly. Neither THC nor over-the-counter CBD has been evaluated or approved by the FDA as a treatment for any medical condition. Epidiolex is the only FDA-approved CBD drug and treats specific pediatric seizure disorders. This page is educational — for any health-related decision, consult a licensed physician.
Side by side
Attribute
Option A
CBD
Option B
THC
Intoxicating?
No — clear-headed
Yes — classic cannabis high
Receptor binding
Indirect modulation
Binds CB1 directly
Reported profile
Calming, non-intoxicating
Biphasic — calm at low dose, anxious at high dose
Legal status (MO)
Hemp-derived CBD federally legal
Regulated — dispensary only, 21+
Drug test risk
Low — isolate only
High — metabolites detectable 30+ days
Typical consumer dose
20 to 100mg+
2.5 to 20mg for non-heavy users
Reported evening effect
Mellow, non-intoxicating
Sedating profile at 5mg+ evening doses
FDA approval
Only Epidiolex — for pediatric epilepsy
Dronabinol/Marinol — for specific conditions only
Choose cbd when
01
Non-intoxicating preference
CBD does not produce the THC high. Consumers who want a cannabis format without cognitive impairment typically choose CBD — especially during work hours. CBD is not FDA-approved for any condition.
02
THC counterbalance
If you took too much THC, CBD can soften the acute experience for some consumers. 25 to 50 mg is a common amount.
03
Drug testing concerns
CBD isolate products contain less than 0.3% THC — detection risk is minimal. If your job drug tests, CBD-only is the safer path.
04
Clear-headed daytime use
CBD doesn't impair cognition or motor skills at common consumer servings. Many users take daytime CBD and function normally.
Choose thc when
01
Stronger body effect
THC produces a more pronounced body sensation than CBD for most consumers. This is not a claim of pain treatment — for pain or any medical condition, see a licensed physician. THC is not FDA-approved for pain.
02
Evening ritual
Consumers frequently report that 5 to 10mg of THC taken 30 to 60 minutes before bed produces a sedating profile. THC is not an FDA-approved sleep aid.
03
Appetite stimulation
THC has a well-documented appetite-stimulation effect. This is the mechanism behind FDA-approved Dronabinol/Marinol for specific oncology and HIV contexts — those prescriptions are accessed through a physician, not a dispensary.
04
Nausea profile
Dronabinol/Marinol (synthetic THC) is FDA-approved for chemotherapy-induced nausea in specific settings. Dispensary cannabis is not FDA-approved for nausea. Patients managing treatment-related nausea should speak with their oncologist.
The verdict
“The honest answer: both cannabinoids have different profiles, and consumers choose products based on personal preference, not medical prescription. CBD-only is the non-intoxicating path. THC carries the classic cannabis high. 1:1 and 2:1 CBD:THC ratio products are popular with consumers who want to soften the THC experience. None of these products are FDA-approved treatments for any medical condition. For any health-related decision, consult a licensed physician.”
Luxury Leaf · The Grove · St. Louis
Shop the shelf
Related
1:1 edibles
Balanced CBD:THC ratio — common daytime format
Explore
Related
CBD-dominant
Non-intoxicating cannabis format
Explore
Related
Edibles
Ratio-labeled gummies and chocolates
Explore
Cannabis and hemp products sold at dispensaries are not FDA-approved to treat, cure, mitigate, or prevent any disease.
CBD vs THC questions
The questions regulars ask when weighing cbd against thc at Luxury Leaf.
THC (tetrahydrocannabinol) is the cannabinoid associated with the classic cannabis high. It binds CB1 receptors in the brain and produces euphoria, appetite effects, and altered perception. CBD (cannabidiol) is non-intoxicating and interacts with the endocannabinoid system indirectly. Neither THC nor over-the-counter CBD has been evaluated or approved by the FDA as a treatment for any medical condition. Epidiolex is the only FDA-approved CBD drug and treats specific pediatric seizure disorders. This page is educational — for any health-related decision, consult a licensed physician.
non-intoxicating preference, thc counterbalance. CBD does not produce the THC high. Consumers who want a cannabis format without cognitive impairment typically choose CBD — especially during work hours. CBD is not FDA-approved for any condition.
stronger body effect, evening ritual. THC produces a more pronounced body sensation than CBD for most consumers. This is not a claim of pain treatment — for pain or any medical condition, see a licensed physician. THC is not FDA-approved for pain.
Yes. Both formats are on the live Dutchie menu. The budtenders at 1463 S Vandeventer Ave can walk you through options in person.
The honest answer: both cannabinoids have different profiles, and consumers choose products based on personal preference, not medical prescription. CBD-only is the non-intoxicating path. THC carries the classic cannabis high. 1:1 and 2:1 CBD:THC ratio products are popular with consumers who want to soften the THC experience. None of these products are FDA-approved treatments for any medical condition. For any health-related decision, consult a licensed physician.
Cannabinoids · Luxury Leaf
1463 S Vandeventer Ave · Open 9 AM – 10 PM daily · 4.9★ on 1,996+ Google reviews.